|
Journal of Lipid Research, Vol. 43, 1602-1609, October 2002
Copyright © 2002 by Lipid Research, Inc.
Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice
Sergio Fazio1,*, ,
Vladimir R. Babaev*,
Michael E. Burleigh ,
Amy S. Major*,
Alyssa H. Hasty* and
MacRae F. Linton1,*,
* Vanderbilt University Medical Center, Departments of Medicine, Nashville, TN 37232
Pathology, Nashville, TN 37232
Pharmacology, Nashville, TN 37232
1 To whom correspondence should be addressed. e-mail: sergio.fazio{at}vanderbilt.edu or macrae.linton{at}vanderbilt.edu
We have previously reported that the introduction of macrophage apoE into mice lacking both apoE and the LDL receptor (apoE-/-/LDLR-/-) through bone marrow transplantation (apoE+/+/LDLR-/- apoE-/-/LDLR-/-) produces progressive accumulation of apoE in plasma without affecting lipid levels. This model provides a tool to study the effects of physiologically regulated amounts of macrophage apoE on atherogenesis in hyperlipidemic animals. Ten-week-old male apoE-/-/LDLR-/- mice were transplanted with either apoE+/+/LDLR-/- (n = 11) or apoE-/-/LDLR-/- (n = 14) marrow. Although there were no differences between the two groups in lipid levels at baseline or at 5 and 9 weeks after transplantation, apoE levels in the apoE+/+LDLR-/- apoE-/-/LDLR-/- mice increased to 4 times the apoE levels of normal mice. This resulted in a 60% decrease in aortic atherosclerosis in the apoE+/+/LDLR-/- apoE-/-/LDLR-/- compared with the apoE-/-/LDLR-/- apoE-/-/LDLR-/- controls, (15,957 ± 1907 vs. 40,115 ± 8302 µm2 ± SEM, respectively). In a separate experiment, apoE+/+/LDLR-/- mice were transplanted with either apoE+/+/LDLR-/- or apoE-/-/LDLR-/- marrow and placed on a high-fat diet for 8 weeks. In the absence of macrophage apoE, lesion area was increased by 75% in the aortic sinus and by 56% in the distal aorta.
These data show that physiologic levels of macrophage apoE in the vessel wall are anti-atherogenic in conditions of severe hyperlipidemia and can affect later stages of plaque development.
Abbreviations: BMT, bone marrow transplant; HSPG, heparan sulfate proteoglycans; LDLR, low density lipoprotein receptor; LXR, liver X receptor; TNF , tumor necrosis factor  Supplementary key words apolipoprotein E low density lipoprotein receptor hyperlipidemia bone marrow transplant

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kockx, W. Jessup, and L. Kritharides
Regulation of Endogenous Apolipoprotein E Secretion by Macrophages
Arterioscler Thromb Vasc Biol,
June 1, 2008;
28(6):
1060 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Atkinson, K. R. Coenen, M. R. Plummer, M. L. Gruen, and A. H. Hasty
Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice
Am J Physiol Endocrinol Metab,
February 1, 2008;
294(2):
E284 - E290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kockx, D. L. Guo, T. Huby, P. Lesnik, J. Kay, T. Sabaretnam, E. Jary, M. Hill, K. Gaus, J. Chapman, et al.
Secretion of Apolipoprotein E From Macrophages Occurs via a Protein Kinase A and Calcium-Dependent Pathway Along the Microtubule Network
Circ. Res.,
September 14, 2007;
101(6):
607 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fan, S. Qiu, C. D. Overton, P. G. Yancey, L. L. Swift, W. G. Jerome, M. F. Linton, and S. Fazio
Impaired Secretion of Apolipoprotein E2 from Macrophages
J. Biol. Chem.,
May 4, 2007;
282(18):
13746 - 13753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yu, W. Zhang, P. G. Yancey, M. J. Koury, Y. Zhang, S. Fazio, and M. F. Linton
Macrophage Apolipoprotein E Reduces Atherosclerosis and Prevents Premature Death in Apolipoprotein E and Scavenger Receptor-Class BI Double-Knockout Mice
Arterioscler Thromb Vasc Biol,
January 1, 2006;
26(1):
150 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tsutsumi and D. W. Losordo
Double Face of VEGF
Circulation,
August 30, 2005;
112(9):
1248 - 1250.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Leppanen, S. Koota, I. Kholova, J. Koponen, C. Fieber, U. Eriksson, K. Alitalo, and S. Yla-Herttuala
Gene Transfers of Vascular Endothelial Growth Factor-A, Vascular Endothelial Growth Factor-B, Vascular Endothelial Growth Factor-C, and Vascular Endothelial Growth Factor-D Have No Effects on Atherosclerosis in Hypercholesterolemic Low-Density Lipoprotein-Receptor/Apolipoprotein B48-Deficient Mice
Circulation,
August 30, 2005;
112(9):
1347 - 1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Hasty, M. R. Plummer, K. H. Weisgraber, M. F. Linton, S. Fazio, and L. L. Swift
The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I
J. Lipid Res.,
July 1, 2005;
46(7):
1433 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fazio and M. F. Linton
Interplay Between Apolipoprotein E and Scavenger Receptor Class B Type I Controls Coronary Atherosclerosis and Lifespan in the Mouse
Circulation,
June 28, 2005;
111(25):
3349 - 3351.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. R. Su, D. E. Dove, A. S. Major, A. H. Hasty, B. Boone, M. F. Linton, and S. Fazio
Reduced ABCA1-Mediated Cholesterol Efflux and Accelerated Atherosclerosis in Apolipoprotein E-Deficient Mice Lacking Macrophage-Derived ACAT1
Circulation,
May 10, 2005;
111(18):
2373 - 2381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Dove, M. F. Linton, and S. Fazio
ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects
Am J Physiol Cell Physiol,
March 1, 2005;
288(3):
C586 - C592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Raffai, S. M. Loeb, and K. H. Weisgraber
Apolipoprotein E Promotes the Regression of Atherosclerosis Independently of Lowering Plasma Cholesterol Levels
Arterioscler Thromb Vasc Biol,
February 1, 2005;
25(2):
436 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nobuhiko, E. Suganuma, V. R. Babaev, A. Fogo, L. L. Swift, M. F. Linton, S. Fazio, I. Ichikawa, and V. Kon
Angiotensin II Amplifies Macrophage-Driven Atherosclerosis
Arterioscler Thromb Vasc Biol,
November 1, 2004;
24(11):
2143 - 2148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Boord, K. Maeda, L. Makowski, V. R. Babaev, S. Fazio, M. F. Linton, and G. S. Hotamisligil
Combined Adipocyte-Macrophage Fatty Acid-Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E-Deficient Mice
Circulation,
September 14, 2004;
110(11):
1492 - 1498.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|